42. The future of David Miyamoto, MD, PhD, and his team’s research

Advances at Mass General Cancer Center by Advances at Mass General Cancer Center

Aug 15, 201800:08:20Science & Medicine

Dr. David Miyamoto explains the impact of his research in prostate cancer, and mentions how it can potentially translate to bladder cancer.

Related Episodes

Continue listening to more episodes from Advances at Mass General Cancer Center.

Nov 9, 2018 - 00:16:19

Drs. Shannon Stott and Brian Nahed explain why their new technology is an important breakthrough for glio...

Nov 9, 2018 - 00:22:23

Drs. Shannon Stott and Brian Nahed describe a new technique that uses microfluidics and engineered nanosu...

Nov 9, 2018 - 00:25:23

In this episode, Drs. Shannon Stott and Brian Nahed explain their backgrounds and share how they met and...

Oct 2, 2018 - 00:10:45

In this episode, Ethel Pereira and Tim Padera share why the protocol in this study isn’t safe to use for...

Oct 2, 2018 - 00:28:31

Tim Padera, PhD, and research fellow, Ethel Pereira, PhD, provide insight into their study of transit tum...

Oct 2, 2018 - 00:25:14

Listen to hear how Tim Padera made his way from being an engineer in Chicago to becoming a cancer researc...

Oct 2, 2018 - 00:10:37

In this episode we’ll hear about Ethel Pereira’s background and how she became interested in science, and...

Aug 15, 2018 - 00:25:22

Dr. David Miyamoto explains his study that examines new technology for treating prostate cancer.